The future of adjuvant chemotherapy for resected non-small cell lung cancer

References

• Vansteenkiste JF. Gefitinib: a novel treatment for non-small cell lung cancer. Expert Rev. Anticancer Ther.4, 5–17 (2004).
   PubMedGoogle Scholar
• American Cancer Society. American Cancer Society Surveillance Research 2002: Cancer Facts and Figures 2002. American Cancer Society, GA, USA (2002).
   Google Scholar
• Mountain CF. Revisions in the international system for staging lung cancer. Chest111, 1710–1717 (1997).
   PubMed Web of Science ®Google Scholar
• Weisenburger T, Gail M, Lung Cancer Study Group (LCSG). Effects of postoperative mediastinal radiation on completely resected Stage II and Stage III epidermoid cancer of the lung. N. Engl. J. Med.315, 1377–1381 (1986).
   PubMed Web of Science ®Google Scholar
• Van Houtte P, Rocmans P, Smets P et al. Postoperative radiation therapy in lung cancer: a controlled trial after resection of curative design. Int. J. Radiat. Oncol. Biol. Phys.6, 983–986 (1980).
   PubMed Web of Science ®Google Scholar
• Feng QF, Wang M, Wang LJ et al. A study of postoperative radiotherapy in patients with non-small cell lung cancer: a randomized trial. Int. J. Radiat. Oncol. Biol. Phys.47, 925–929 (2000).
   PubMed Web of Science ®Google Scholar
• Trodella L, Granone P, Valente S et al. Adjuvant radiotherapy in non-small cell lung cancer with pathological Stage I: definitive results of a Phase III randomized trial. Radiother. Oncol.62, 11–19 (2002).
   PubMed Web of Science ®Google Scholar
• Taylor NA, Liao ZX, Stevens C et al. Postoperative radiotherapy increases locoregional control of patients with Stage IIIA non-small cell lung cancer treated with induction chemotherapy followed by surgery. Int. J. Radiat. Oncol. Biol. Phys.56, 616–625 (2003).
   PubMed Web of Science ®Google Scholar
• Dautzenberg B, Arriagada R, Chammard AB et al. A controlled study of postoperative radiotherapy for patients with completely resected non-small cell lung carcinoma. Groupe d’Etude et de Traitement des Cancers Bronchiques. Cancer86, 265–273 (1999).
   PubMed Web of Science ®Google Scholar
• PORT Meta-Analysis Trialists Group. Postoperative radiotherapy in non-small cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials. Lancet352, 257–263 (1998).
   PubMed Web of Science ®Google Scholar
• PORT Meta-analysis Trialists Group. Postoperative radiotherapy in non-small cell lung cancer. Cochrane Database Syst. Rev.CD002142, (2003).
   Google Scholar
• Mountain CF, McMurtrey MJ, Frazier OH. Regional extension of lung cancer. Int. J. Radiat. Oncol. Biol. Phys.6, 1012–1020 (1980).
   Google Scholar
• Feld R, Rubinstein L, Weisenburger T. Sites of recurrence in resected Stage I non-small-cell lung cancer: a guide for future studies. J. Clin. Oncol.2, 1352–1358 (1984).
   PubMed Web of Science ®Google Scholar
• Holmes EC. Surgical adjuvant therapy of non-small cell lung cancer. Chest89, 295S–300S (1986).
   Google Scholar
• Lad T, Rubinstein L, Sadeghi A. The benefit of adjuvant treatment for resected locally advanced non-small-cell lung cancer. J. Clin. Oncol.6, 9–17 (1988).
   PubMed Web of Science ®Google Scholar
• Ohta M, Tsuchiya R, Shimoyama M et al. Adjuvant chemotherapy for completely resected Stage III non-small cell lung cancer. J. Thorac. Cardiovasc. Surg.106, 703–708 (1993).
   PubMed Web of Science ®Google Scholar
• Early Breast Cancer Trialists’ Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet339, 71–85 (1992).
   PubMed Web of Science ®Google Scholar
• International Multicentre Pooled Analysis Of Colon Cancer Trials (IMPACT) Investigators. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. Lancet345, 939–944 (1995).
   PubMed Web of Science ®Google Scholar
• Mountain CF, Vincent RG, Sealy R, Khalil KG. A clinical trial of CCNU as surgical adjuvant treatment for patients with surgical Stage I and Stage II non-small cell lung cancer: preliminary findings. In: Lung Cancer: Progress in Therapeutic Research. Muggia FM, Rozencweig M (Eds), Raven Press, NY, USA, 421–431 (1979).
   Google Scholar
• Shields TW, Higgins GA, Humphrey EW et al. Prolonged intermittent adjuvant chemotherapy with CCNU and hydroxyurea after resection of carcinoma of the lung. Cancer50, 1713–1721 (1982).
   PubMed Web of Science ®Google Scholar
• Girling DJ, Stott H, Stephens RJ, Fox W. Fifteen-year follow-up of all patients in a study of postoperative chemotherapy for bronchial carcinoma. Br. J. Cancer52, 867–873 (1985).
   PubMed Web of Science ®Google Scholar
• Holmes EC, Gail M. Surgical adjuvant therapy for Stage II and Stage III adenocarcinoma and large-cell undifferentiated carcinoma. J. Clin. Oncol.4, 710–715 (1986).
   PubMed Web of Science ®Google Scholar
• Niiranen A, Niitamo-Korhonen S, Kouri M, Assendelft A, Mattson K, Pyrhonen S. Adjuvant chemotherapy after radical surgery for non-small cell lung cancer: a randomized study. J. Clin. Oncol.10, 1927–1932 (1992).
   PubMed Web of Science ®Google Scholar
• Study Group of Adjuvant Chemotherapy for Lung Cancer (Chubu Japan). A randomized trial of postoperative adjuvant chemotherapy in non-small cell lung cancer (the second co-operative study). Eur. J. Surg. Oncol.21, 69–77 (1995).
   PubMedGoogle Scholar
• Ichinose Y, Takanashi N, Yano T et al. A Phase II trial of oral tegafur and uracil plus cisplatin in patients with inoperable non-small cell lung cancer. Cancer75, 2677–2680 (1995).
   PubMed Web of Science ®Google Scholar
• Feld R, Rubinstein L, Thomas PA. Adjuvant chemotherapy with cyclophosphamide, doxorubicin, and cisplatin in patients with completely resected Stage I non-small cell lung cancer. J. Natl Cancer Inst.85, 299–306 (1993).
   PubMed Web of Science ®Google Scholar
• Figlin RA, Piantadosi S. A Phase 3 randomized trial of immediate combination chemotherapy vs. delayed combination chemotherapy in patients with completely resected Stage II and III non-small cell carcinoma of the lung. Chest106, 310S–312S (1994).
   PubMed Web of Science ®Google Scholar
• Non-Small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Br. Med. J.311, 899–909 (1995).
   PubMed Web of Science ®Google Scholar
• The International Adjuvant Lung Cancer Trial Collaborative Group, Arriagada R, Bergman B et al. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small cell lung cancer. N. Engl. J. Med.350, 351–360 (2004).
   PubMed Web of Science ®Google Scholar
• Scagliotti GV, Fossati R, Torri V et al. Randomized study of adjuvant chemotherapy for completely resected Stage I, II, or IIIA non-small cell lung cancer. J. Natl Cancer Inst.95, 1453–1461 (2003).
   PubMed Web of Science ®Google Scholar
• Keller SM, Adak S, Wagner H et al. A randomized trial of postoperative adjuvant therapy in patients with completely resected Stage II or IIIa non-small cell lung cancer. N. Engl. J. Med.343, 1217–1222 (2000).
   PubMed Web of Science ®Google Scholar
• Winton TL, Livingston R, Johnson D et al. A prospective randomized trial of adjuvant vinorelbine (VIN) and cisplatin (CIS) in completely resected Stage IB and II non-small cell lung cancer (NSCLC) – Intergroup JBR10. Proc. Am. Soc. Clin. Oncol. USA23, (2004) (Abstract 619).
   Google Scholar
• Waller D, Fairlamb DJ, Gower N et al. The Big Lung Trial (BLT) determining the value of cisplatin-based chemotherapy for all patients with non-small cell lung cancer (NSCLC). Preliminary results in the surgical setting. Lung Cancer41(Suppl. 2), 54S (2003).
   Google Scholar
• Strauss GM, Herndon J, Maddaus MA et al. Randomized trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in Stage IB non-small cell lung cancer (NSCLC). Report of CALGB protocol 9633. Proc. Am. Soc. Clin. Oncol. USA23 (2004) (Abstract 619).
   Google Scholar
• Tada H, Tsuchiya R, Ichinose Y et al. A randomized trial comparing adjuvant chemotherapy versus surgery alone for completely resected pN2 non-small cell lung cancer (JCOG9304). Lung Cancer43, 167–173 (2004).
   PubMed Web of Science ®Google Scholar
• Wada H, Miyahara R, Tanaka F, Hitomi S. Postoperative adjuvant chemotherapy with PVM (Cisplatin + Vindesine + Mitomycin C) and UFT (Uracil + Tegaful) in resected Stage I-II NSCLC (non-small cell lung cancer): a randomized clinical trial. West Japan Study Group for lung cancer surgery (WJSG). Eur J. Cardiothorac. Surg15, 438–443 (1999).
   PubMed Web of Science ®Google Scholar
• Wada H, Hitomi S, Teramatsu T. Adjuvant chemotherapy after complete resection in non-small cell lung cancer. West Japan Study Group for Lung Cancer Surgery. J. Clin. Oncol.14, 1048–1054 (1996).
   PubMed Web of Science ®Google Scholar
• Kato H, Ichinose Y, Ohta M et al. A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung. N. Engl. J. Med.350, 1713–1721 (2004).
   PubMed Web of Science ®Google Scholar
• Endo C, Saito Y, Iwanami H et al. A randomized trial of postoperative UFT therapy in p Stage I, II non-small cell lung cancer: North-East Japan Study Group for Lung Cancer Surgery. Lung Cancer40, 181–186 (2003).
   PubMed Web of Science ®Google Scholar
• Hamada C, Ohta M, Wada H et al. Survival benefit of oral UFT for adjuvant chemotherapy after completely resected non-small cell lung cancer. Proc. Am. Soc. Clin. Oncol. USA23, 615A (2004).
   Google Scholar
• Smythe WR. Treatment of Stage I non-small cell lung carcinoma. Chest123(Suppl. 1), 181S–187S (2003).
   PubMed Web of Science ®Google Scholar
• Scott WJ, Howington J, Movsas B. Treatment of Stage II non-small cell lung cancer. Chest123(Suppl. 1), 188S–201S (2003).
   Google Scholar
• Robinson LA, Wagner H, Ruckdeschel JC. Treatment of Stage IIIA non-small cell lung cancer. Chest123(Suppl. 1), 202S–220S (2003).
   PubMed Web of Science ®Google Scholar
• Verweij JB, Van Zanten T, Souren T, Golding R, Pinedo H. Prospective study of the dose relationship of mitomycin C induced interstitial pneumonitis. Cancer60, 756–761 (1987).
   PubMed Web of Science ®Google Scholar
• Depierre A, Milleron B, Moro-Sibilot D et al. Preoperative chemotherapy followed by surgery compared with primary surgery in resectable Stage I (except T1N0), II, and IIIa non-small cell lung cancer. J. Clin. Oncol.20, 247–253 (2002).
   PubMed Web of Science ®Google Scholar
• Blum RH. Adjuvant chemotherapy for lung cancer – a new standard of care. N. Engl. J. Med.350, 404–405 (2004).
   PubMed Web of Science ®Google Scholar
• Rosell R, Gatzemeier U, Betticher DC et al. Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small cell lung cancer: a co-operative multinational trial. Ann. Oncol.13, 1539–1549 (2002).
   PubMed Web of Science ®Google Scholar
• Baggstrom MQ, Socinski MA, Hensing TA et al. Third generation chemotherapy regimens (3GR) improve survival over second generation regimens (2GR) in Stage IIIB/IV non-small cell lung cancer (NSCLC): a meta-analysis of the published literature. Proc. Am. Soc. Clin. Oncol.21, 306A (2002).
   Web of Science ®Google Scholar
• Harper P, Plunkett T, Khayat D. Quality trials and quality of life in non-small-cell lung cancer. J. Clin. Oncol.21, 3007–3008 (2003).
   PubMed Web of Science ®Google Scholar
• Blackhall F, Thatcher N. Chemotherapy for advanced lung cancer. Eur. J. Cancer40, 2345–2348 (2004).
   PubMed Web of Science ®Google Scholar
• Spira A, Ettinger DS. Multidisciplinary management of lung cancer. N. Engl. J. Med.350, 379–392 (2004).
   PubMed Web of Science ®Google Scholar
• Vansteenkiste JF, Stroobants SG, De Leyn PR et al. Prognostic importance of the standardized uptake value on FDG-PET scan in non-small cell lung cancer: an analysis of 125 cases. J. Clin. Oncol.17, 3201–3206 (1999).
   PubMed Web of Science ®Google Scholar
• Rosell R, Danenberg KD, Alberola V et al. Ribonucleotide reductase messenger RNA expression and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients. Clin. Cancer Res.10, 1318–1325 (2004).
   PubMed Web of Science ®Google Scholar
• Rosell R, Gomez Codina J, Camps C et al. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. N. Engl. J. Med.330, 153–158 (1994).
   PubMed Web of Science ®Google Scholar
• Roth J, Fossella F, Komaki RP et al. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable Stage IIIA non-small cell lung cancer. J. Natl Cancer Inst.86, 673–680 (1994).
   PubMed Web of Science ®Google Scholar
• Fukuoka M, Yano S, Giaccone G et al. Multi-institutional randomized Phase II trial of gefitinib for previously treated patients with advanced non-small cell lung cancer. J. Clin. Oncol.21, 2237–2246 (2003).
   PubMed Web of Science ®Google Scholar
• Onn A, Tsuboi M, Thatcher N. Treatment of non-small cell lung cancer: a perspective on the recent advances and the experience with gefitinib. Br. J. Cancer91(Suppl. 2), 11S–17S (2004).
   PubMed Web of Science ®Google Scholar